Kinetics of arsenic methylation by freshly isolated B6C3F1 mouse hepatocytes
β Scribed by Gregory L. Kedderis; Amy R. Elmore; Eric A. Crecelius; Janice W. Yager; Thomas L. Goldsworthy
- Book ID
- 113517361
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 166 KB
- Volume
- 161
- Category
- Article
- ISSN
- 0009-2797
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The effects of different liver tumor-promoting treatments (i.e., a choline-devoid, methionine-deficient (CMD) diet, phenobarbital (PB), or both) on Ha-ras and raf methylation status and expression were determined in mouse strains with different susceptibilities to liver tumor formation: the relative
## Abstract The liver tumorβprone B6C3F1 mouse (C57BL/6 β Γ C3H/Heβ), in conjunction with the more susceptible C3H/He paternal strain and the resistant C57BL/6 maternal strain, is an excellent model for studying the mechanisms involved in carcinogenesis. The study reported here indicated that the B
The abilities of structural congeners of phenobarbital to induce immunoreactive hepatic cytochrome P450 2B (CYP2B) protein and associated catalytic activity (benzyloxyresorufin 0-dealkylation) in the male B6C3F1 mouse were examined. Interspecies differences in inducing ability were examined through